232 related articles for article (PubMed ID: 23636667)
1. Prognostic value of telomere attrition in patients with aplastic anemia.
Scheinberg P
Int J Hematol; 2013 May; 97(5):553-7. PubMed ID: 23636667
[TBL] [Abstract][Full Text] [Related]
2. Telomerase gene therapy rescues telomere length, bone marrow aplasia, and survival in mice with aplastic anemia.
Bär C; Povedano JM; Serrano R; Benitez-Buelga C; Popkes M; Formentini I; Bobadilla M; Bosch F; Blasco MA
Blood; 2016 Apr; 127(14):1770-9. PubMed ID: 26903545
[TBL] [Abstract][Full Text] [Related]
3. Association of telomere length of peripheral blood leukocytes with hematopoietic relapse, malignant transformation, and survival in severe aplastic anemia.
Scheinberg P; Cooper JN; Sloand EM; Wu CO; Calado RT; Young NS
JAMA; 2010 Sep; 304(12):1358-64. PubMed ID: 20858879
[TBL] [Abstract][Full Text] [Related]
4. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia.
Yamaguchi H; Calado RT; Ly H; Kajigaya S; Baerlocher GM; Chanock SJ; Lansdorp PM; Young NS
N Engl J Med; 2005 Apr; 352(14):1413-24. PubMed ID: 15814878
[TBL] [Abstract][Full Text] [Related]
5. Telomere elongation and clinical response to androgen treatment in a patient with aplastic anemia and a heterozygous hTERT gene mutation.
Ziegler P; Schrezenmeier H; Akkad J; Brassat U; Vankann L; Panse J; Wilop S; Balabanov S; Schwarz K; Martens UM; Brümmendorf TH
Ann Hematol; 2012 Jul; 91(7):1115-20. PubMed ID: 22476886
[TBL] [Abstract][Full Text] [Related]
6. Erosion of telomeric single-stranded overhang in patients with aplastic anaemia carrying telomerase complex mutations.
Calado RT; Regal JA; Kajigaya S; Young NS
Eur J Clin Invest; 2009 Nov; 39(11):1025-32. PubMed ID: 19674077
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow failure and the new telomere diseases: practice and research.
Young NS
Hematology; 2012 Apr; 17 Suppl 1():S18-21. PubMed ID: 22507770
[TBL] [Abstract][Full Text] [Related]
8. Defective telomere elongation and hematopoiesis from telomerase-mutant aplastic anemia iPSCs.
Winkler T; Hong SG; Decker JE; Morgan MJ; Wu C; Hughes WM; Yang Y; Wangsa D; Padilla-Nash HM; Ried T; Young NS; Dunbar CE; Calado RT
J Clin Invest; 2013 May; 123(5):1952-63. PubMed ID: 23585473
[TBL] [Abstract][Full Text] [Related]
9. Telomeres and marrow failure.
Calado RT
Hematology Am Soc Hematol Educ Program; 2009; ():338-43. PubMed ID: 20008219
[TBL] [Abstract][Full Text] [Related]
10. Telomere maintenance and human bone marrow failure.
Calado RT; Young NS
Blood; 2008 May; 111(9):4446-55. PubMed ID: 18239083
[TBL] [Abstract][Full Text] [Related]
11. Telomere length variation and telomerase activity expression in patients with congenital and acquired aplastic anemia.
Polychronopoulou S; Koutroumba P
Acta Haematol; 2004; 111(3):125-31. PubMed ID: 15034232
[TBL] [Abstract][Full Text] [Related]
12. Structural Analysis Reveals the Deleterious Effects of Telomerase Mutations in Bone Marrow Failure Syndromes.
Hoffman H; Rice C; Skordalakes E
J Biol Chem; 2017 Mar; 292(11):4593-4601. PubMed ID: 28154186
[TBL] [Abstract][Full Text] [Related]
13. TERC haploid cell reprogramming: a novel therapeutic strategy for aplastic anemia.
Tang X; Xu R; Wang Y; Chen K; Cui S
Mol Med; 2023 Jul; 29(1):94. PubMed ID: 37424004
[TBL] [Abstract][Full Text] [Related]
14. Aplastic anemia: pathophysiology and treatment.
Young NS; Bacigalupo A; Marsh JC
Biol Blood Marrow Transplant; 2010 Jan; 16(1 Suppl):S119-25. PubMed ID: 19782144
[TBL] [Abstract][Full Text] [Related]
15. [The relationship of telomere and telomerase activity with outcome of aplastic anemia after immunosuppressive therapy].
Song JY; Kuang LP; Wang Y; Li YH; Wu JL; Zhang H; Li L; Wang YC; Jiang ZJ; Xiao Y
Zhonghua Xue Ye Xue Za Zhi; 2013 Sep; 34(9):771-6. PubMed ID: 24103875
[TBL] [Abstract][Full Text] [Related]
16. Paroxysmal nocturnal hemoglobinuria and telomere length predicts response to immunosuppressive therapy in pediatric aplastic anemia.
Narita A; Muramatsu H; Sekiya Y; Okuno Y; Sakaguchi H; Nishio N; Yoshida N; Wang X; Xu Y; Kawashima N; Doisaki S; Hama A; Takahashi Y; Kudo K; Moritake H; Kobayashi M; Kobayashi R; Ito E; Yabe H; Ohga S; Ohara A; Kojima S;
Haematologica; 2015 Dec; 100(12):1546-52. PubMed ID: 26315930
[TBL] [Abstract][Full Text] [Related]
17. Elevated senescence in the bone marrow mesenchymal stem cells of acquired aplastic anemia patients: A possible implication of DNA damage responses and telomere attrition.
Saxena P; Srivastava J; Rai B; Tripathy NK; Raza S; Sinha RA; Gupta R; Yadav S; Nityanand S; Chaturvedi CP
Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167025. PubMed ID: 38237741
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure.
Vulliamy TJ; Walne A; Baskaradas A; Mason PJ; Marrone A; Dokal I
Blood Cells Mol Dis; 2005; 34(3):257-63. PubMed ID: 15885610
[TBL] [Abstract][Full Text] [Related]
19. Updates on the pathophysiology and treatment of aplastic anemia: a comprehensive review.
Boddu PC; Kadia TM
Expert Rev Hematol; 2017 May; 10(5):433-448. PubMed ID: 28452257
[TBL] [Abstract][Full Text] [Related]
20. Telomerase gene mutation screening in Chinese patients with aplastic anemia.
Han B; Liu B; Cui W; Wang X; Lin J; Zhao Y
Leuk Res; 2010 Feb; 34(2):258-60. PubMed ID: 19942288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
